Inventor · disambiguated record
Nicholas Andrew Magnus
Also filed as: MAGNUS NICHOLAS A · MAGNUS NICHOLAS ANDREW
5 granted patents·2 pending applications·12 citations·filing 1999–2024
71Inventor score
Top patents by PatentIndex Score
7 records- 0181US11926634B2Processes for the preparation of selective estrogen receptor degradersLILLY CO ELI·Filed 2023·Granted Mar 12, 2024·1 cites·20 claims
- 0266US6770763B2Asymmetric synthesis of amino-pyrrolidinonesBRISTOL MYERS SQUIBB CO·Filed 2003·Granted Aug 3, 2004·4 cites·12 claims
- 0358US2024199629A1Processes for the preparation of selective estrogen receptor degradersLILLY CO ELI·Filed 2024·Application pending·0 cites
- 0457US7598423B2Potentiators of glutamate receptorsLILLY CO ELI·Filed 2005·Granted Oct 6, 2009·0 cites·23 claims
- 0556US6175009B1Process for the preparation of quinazolinonesDU PONT PHARM CO·Filed 1999·Granted Jan 16, 2001·7 cites·25 claims
- 0650US2023322682A1Processes and intermediates for the preparation of (s)-5-amino-3-(4-((5-fluoro-2-methoxybenzamido)methyl)phenyl)-1-(1,1,1-trifluoropropane-2-yl)-1h-pyrazole-4-carboxamideLOXO ONCOLOGY INC·Filed 2021·Application pending·0 cites
- 0745US12454512B2Processes and intermediates for the preparation of 2-(2,6-dichlorophenyl)-1-[(1S,3R)-3-(hydroxymethyl)-5-(3-hydroxy-3-methylbutyl)-1-methyl-3,4-dihydroisoquinolin-2(1H)-yl]ethenoneLILLY CO ELI·Filed 2020·Granted Oct 28, 2025·0 cites·9 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →